About This Source - CGTN
This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.
Recent from CGTN:
CGTN published this video item, entitled “China to vaccinate high-risk groups this winter with three inoculations” – below is their description.
China has approved emergency use of three COVID-19 vaccines in June, two from CNBG Sinopharm and one from Sinovac. The State Council task force on COVID-19 says since emergency use started in July, more than one million doses have been administered.
China has approved the emergency use of three COVID-19 vaccines in June, two from CNBG Sinopharm and one from Sinovac. The State Council task force on COVID-19 says since emergency use started in July, more than one million doses have been administered.CGTN YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: China
7 Recent Items: China
In This Story: COVID-19
Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.
Symptoms of coronavirus
The main symptoms of coronavirus are:
- a persistent new cough (non productive, dry)
- a high temperature (e.g. head feels warm to the touch)
- shortness of breath (if this is abnormal for the individual, or increased)
Latest News about Covid-19
Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.
5 Recent Items: COVID-19
In This Story: Sinopharm
China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.